Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2021-10-21 00:00:00 ET · period of report 2021-10-19 · accession 0001209191-21-061274 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-21 | 2021-10-19 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2021-10-21 | 2021-10-19 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $38.87 | -1,375 | 107.7K | -1% | -$53.4K |
| D | 2021-10-21 | 2021-10-19 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $0.00 | -1,375 | 248.4K | -0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-19 | M | A | 1,375 | $1.53 | 109,075 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-19 | S | D | 1,375 | $38.87 | 107,700 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-10-19 | M | D | 1,375 | $0.00 | 248,380 | D | $1.53 · — to 2028-01-26 | 1,375 Common Stock | (F2) 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. |